Control of the chromatin response to DNA damage: Histone proteins pull the strings.

Chromatin dynamics DNA damage repair Histone post-translational modifications Histone variants Transcriptional regulation

Journal

Seminars in cell & developmental biology
ISSN: 1096-3634
Titre abrégé: Semin Cell Dev Biol
Pays: England
ID NLM: 9607332

Informations de publication

Date de publication:
05 2021
Historique:
received: 12 03 2020
revised: 29 06 2020
accepted: 01 07 2020
pubmed: 22 7 2020
medline: 3 2 2022
entrez: 22 7 2020
Statut: ppublish

Résumé

DNA damage challenges both genome integrity and its organization with histone proteins into chromatin, with prominent alterations in histone variant dynamics and histone modifications. While these alterations jeopardize epigenome stability, they are also instrumental for an efficient and timely response to DNA damage. Here, we review recent findings illustrating how histone variants and post-translational modifications actively contribute to and control the DNA damage response. We present accumulating evidence that histone protein changes help relieve the chromatin barrier to DNA repair by regulating chromatin compaction and mobility. We also highlight how histone modifications and variants control transcriptional silencing at damage sites, and we describe both pre-existing and DNA damage-induced chromatin features that govern DNA damage signaling and guide DNA repair pathway choice. We discuss how histone dynamics ultimately participate to the restoration of epigenome integrity and present our current knowledge of key molecular players involved in these critical processes.

Identifiants

pubmed: 32690375
pii: S1084-9521(19)30096-5
doi: 10.1016/j.semcdb.2020.07.002
pii:
doi:

Substances chimiques

Chromatin 0
Histones 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-87

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Juliette Ferrand (J)

Epigenetics & Cell Fate Centre, UMR7216 CNRS, Université de Paris, Paris, France.

Alexandre Plessier (A)

Epigenetics & Cell Fate Centre, UMR7216 CNRS, Université de Paris, Paris, France.

Sophie E Polo (SE)

Epigenetics & Cell Fate Centre, UMR7216 CNRS, Université de Paris, Paris, France. Electronic address: sophie.polo@u-paris.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH